Pyramax receives positive opinion from the EMA
Pyramax, a fixed-dose combination of pyronaridine and artesunate, becomes the first antimalarial to be granted a positive scientific opinion from the European Medicines Agency (EMA) under Article 58. This once daily, 3-day treatment is indicated for acute, uncomplicated Plasmodium falciparum and blood-stage Plasmodium vivax malaria in adults and children over 20 kg....
Source: PhysOrg - Tuesday, 21 February
Related articles:
- Older News
- 3Vote! Hedge funds more like guardian angels than vultures: research
PhysOrg - Tuesday, 8 May
- 3Vote! NASA Receives Clean Audit Opinion
NASA - Tuesday, 15 November, 2011
- 8Vote! Abuse from other universes -- a second opinion
- 19Vote! Key to Swaying Mass Opinion Found
(LiveScience.com)
Yahoo Science News - Tuesday, 26 July, 2011
- 29Vote! Computers learn to spot 'opinion spam' in online reviews
- 16Vote! NYTimes: Consumer pay wall response 'positive'
CNET - Thursday, 21 July, 2011
- 20Vote! Is 'positive aging' possible?
